Cetuximab treatment in a patient with metastatic colorectal cancer and psoriasis

Current Oncology

Volumn 15, Issue 4, 2008, Pages 31-32

  Neyns, Bart ^a   Meert, V ^a   Vandenbroucke, F ^a  

^a UNIVERSITY HOSPITAL BRUSSELS   (Belgium)

Author keywords

Cetuximab; Colorectal cancer; Psoriasis; Skin toxicity

Indexed keywords

CALCIPOTRIOL; CAPECITABINE; CETUXIMAB; CLINDAMYCIN; FLUOROURACIL; FOLINIC ACID; IRINOTECAN; OXALIPLATIN; TUMOR ANTIGEN;

AGED; CANCER GROWTH; CASE REPORT; COLORECTAL CANCER; COLORECTAL SURGERY; DERMATITIS; DRUG RESPONSE; FOLLICULITIS; HUMAN; IMMUNOHISTOCHEMISTRY; LIVER METASTASIS; MALE; MONOTHERAPY; PSORIASIS; REVIEW;

EID: 54349117019     PISSN: None     EISSN: 17187729     Source Type: Journal    
DOI: 10.3747/co.v15i4.228     Document Type: Review

References (5)

1. Trivin F, Boucher E, Raoul JL. Complete sustained regression of extensive psoriasis with cetuximab combination chemotherapy. Acta Oncol 2004;43:592-3.
2. Windrum P, Jones FG, McMullin MF. Adoptive immunotherapy after bone marrow transplantation in a patient with relapsed acute myeloid leukaemia and severe psoriasis. Bone Marrow Transplant 2004;34:281-2.
3. Kojima. R, Kami M, Kim SW, et al. Induction of graft-versus-autoimmune (GVA) disease effect against refractory psoriasis by complete donor-type chimerism and graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant 2003;32:439-42.
4. Kanamori H, Tanaka M, Kawaguchi H, et al. Resolution of psoriasis following allogencic bone marrow transplantation for chronic myelogenous leukemia: case report and review of the literature. Am J Hematol 2002;71:41-4.
5. King LE Jr, Gates RE, Stoscheck CM, Nanney LB. Epidermal growth factor/ transforming growth factor alpha receptors and psoriasis. J Invest Dermatol 1990;95:10S-12S.